Thompson Siegel & Walmsley LLC Bristol Myers Squibb CO Transaction History

Thompson Siegel & Walmsley LLC

$6.24 Billion
Q2 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 158,654 shares of BMY stock, worth $8.44 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

158,654

Previous 158,454 0.13%

Holding current value

$8.44 Million

Previous $8.59 Million 23.32%

% of portfolio

0.11%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $8,050 - $10,598	200 Added 0.13%	158,654 $6.59 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $955,650 - $1.06 Million	15,000 Added 10.46%	158,454 $10.1 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $1.42 Million - $1.61 Million	21,550 Added 17.68%	143,454 $9.94 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $8.35 Million - $9.89 Million	121,904 New	121,904 $8.77 Million
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $6,792 - $4.01 Million	-52,250 Reduced 25.85%	149,904 $10.7 Million
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $60,782 - $66,943	-837 Reduced 0.41%	202,154 $15.6 Million
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $2.77 Million - $3.33 Million	45,112 Added 28.57%	202,991 $14.8 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $2.08 Million - $2.42 Million	38,750 Added 32.53%	157,879 $9.84 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $568,032 - $665,376	9,600 Added 8.76%	119,129 $7.05 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $167,872 - $188,807	2,829 Added 2.65%	109,529 $6.92 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $71,482 - $81,002	-1,238 Reduced 1.15%	106,700 $6.62 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $63,575 - $70,449	-1,107 Reduced 1.02%	107,938 $6.51 Million
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $182,660 - $213,547	-3,332 Reduced 2.97%	109,045 $6.41 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $1.7 Million - $2.48 Million	36,708 Added 48.51%	112,377 $6.26 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $2.9 Million - $3.78 Million	58,831 Added 349.39%	75,669 $4.86 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $15,824 - $18,762	-370 Reduced 2.15%	16,838 $854,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $64,252 - $71,049	1,440 Added 9.13%	17,208 $780,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $10,971 - $14,226	-225 Reduced 1.41%	15,768 $820,000
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $7,680 - $9,572	-152 Reduced 0.94%	15,993 $885,000
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $23,976 - $26,139	400 Added 2.54%	16,145 $989,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $28,830 - $33,272	522 Added 3.43%	15,745 $1 Million
Q2 2017 Aug 09, 2017	BUY	N/A	15,223	15,223 $848,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Bristol Myers Squibb CO Transaction History